← SynDRA
2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one
SynDRA canonical compound SYN1966406 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MTOR | PRKDC |
|---|
| Mechanism of action | DNA dependent protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- DNA dependent protein kinase inhibitor
- PRKDC INHIBITOR
- MTOR INHIBITOR
Cross-references
Synonyms
- Compound 401
- 2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one
- 2-(morpholin-4-yl)pyrimido[2,1-a]isoquinolin-4-one
- CHEMBL179242
- 2-(4-MORPHOLINYL)-4H-PYRIMIDO[2,1-A]ISOQUINOLIN-4-ONE
- Compound401
- SCHEMBL10092321
- KS-00001DEG
- CTK4D2994
- DTXSID20434626
- MolPort-023-276-726
- HMS3229D15
- EX-A1016
- BCP04303
- BDBM50159620
- ZINC13608047
- AKOS016369524
- CS-5624
- NCGC00378805-02
- HY-19341
- KB-224235
- M2537
- B7337
- S-7713
- J-010456
Look up 2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one in the interactive SynDRA portal →